Namenda for Chronic Headache and Migraine Prevention
Another medication can now be added to the growing list of medications shown to be effective for prevention of headaches and Migraine attacks. Namenda (memantine HCL, Forest Pharmaceuticals) was approved for use in the United States in October, 2003, more than a decade after its use began in Europe under the brand names Ebixa and Axura. It's classified as an orally active NMDA receptor antagonist. Namenda (memantine hydrochloride) is approved for the treatment of "moderate to severe dementia of the Alzheimer's type."
John Claude Krusz, Ph.D., M.D., and Diane Cammarata, ANRP, BC, have been studying the use of Namenda in the treatment of chronic Migraine disease and tension-type headache (TTH) in Dr. Krusz's Dallas practice. The results have been quite promising. Feature Article